€105.50 F4DE.DE Ossiam Biodiversity XETRA pre-market Mar 2026: oversold bounce

The F4DE.DE stock opened pre-market at €105.50, trading near its year low and setting up a classic oversold bounce scenario. Volume is thin at 29 shares, so price moves can be abrupt. We highlight short-term entry points, stop levels, and realistic upside using Meyka AI’s model. This piece is an analyst-style, data-led view of Ossiam Food for Biodiversity UCITS ETF on XETRA in Germany, linking sector context to trade tactics.

Price snapshot: F4DE.DE stock

The ETF trades on XETRA in Germany at €105.50 with a prior close of €105.92. The intraday range on the last quote was €105.44 to €106.22, while the 52-week high is €126.88 and low €105.40. The 50-day average is €107.46 and the 200-day average is €113.13, showing the fund sits below both moving averages.

Liquidity and volatility signals for F4DE.DE stock

Trading is very light: volume 29 versus an average of 16, giving a relative volume of 1.81. Low share turnover raises execution and slippage risk, and technical indicators are limited by sparse data. One clear fact: thin liquidity magnifies short-term moves and makes this ETF a candidate for an oversold bounce trade rather than long-term core exposure.

Why an oversold bounce matters for F4DE.DE stock

F4DE.DE stock is down 14.85% YTD and sits at the lower bound of its 12-month range. That proximity to the year low supports a mean reversion setup where short-term buyers can push price back toward the 50-day mean. The oversold bounce strategy targets a measured rebound, not a regime change in fundamentals.

Meyka Grade & technicals: F4DE.DE stock

Meyka AI rates F4DE.DE with a score of 63.36 out of 100, graded B with a suggestion: HOLD. This grade factors S&P 500 comparison, sector and industry performance, financial growth, key metrics, forecasts, and analyst consensus. Technical indicators are muted because the ETF has low trading history, but moving averages and the proximity to the year low guide tactical entries.

Meyka AI forecast and price targets for F4DE.DE stock

Meyka AI’s forecast model projects a quarterly level of €98.23 and a yearly target of €117.55. Relative to the current price of €105.50, the quarterly projection implies a near-term downside of -6.89%, while the yearly projection implies an upside of 11.42%. For tactical trading we set a conservative price target of €112.00 (implied upside 6.16%) and a stretch target aligned with the model at €117.55. Forecasts are model-based projections and not guarantees.

Sector and valuation context for F4DE.DE stock

The fund sits in the Asset Management industry inside Financial Services, and carries a market cap of €19,833,789.00. Compared with larger Financial Services ETFs, this niche biodiversity strategy shows higher idiosyncratic risk and lower liquidity. Sector performance is mixed in Germany, so F4DE.DE’s moves reflect fund flows into thematic and sustainable ETFs more than company earnings.

Final Thoughts

Key takeaway: F4DE.DE stock at €105.50 is a textbook oversold bounce candidate because it trades near its 52-week low with muted liquidity. Short-term traders can consider a measured long with a conservative price target of €112.00 and a tighter stop to manage slippage. Meyka AI’s model offers a yearly projection of €117.55, implying 11.42% upside from today. There is also a quarterly model projection of €98.23, which translates to a -6.89% downside if the ETF weakens further. We recommend position sizing aligned with the dataset’s low liquidity and treating Meyka AI forecasts as model-based guidance, not guarantees. For background on the issuer and listing, see the fund provider and exchange pages Ossiam and Deutsche Börse. Internal coverage and live signals are available on the Meyka stock page for F4DE.DE at Meyka stock page.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.